First US Home Collection COVID-19 Test Gets Green Light
Executive Summary
US regulators have authorized the first COVID-19 test that lets people take a sample of mucus inside their nose at home to check for the novel coronavirus. The maker of the test, LabCorp, says the test will be available in most states within the next few weeks – but health care workers will be given the tests before the general public.
You may also be interested in...
US FDA Highlights OTC Market With Template To Boost COVID-19 Test Development
FDA template explains what information the agency wants to see in regulating COVID-19 tests to be performed outside the laboratory environment.
FDA Boosts Development Of OTC COVID-19 Tests With New Template
A new template from the US FDA explains what information the agency wants to see in regulating COVID-19 tests to be performed outside the laboratory environment.
FDA Greenlights Second Pooled Sample COVID-19 Test As Crucial Tool To Reopen US Economy
US regulators have re-issued an EUA to LabCorp’s COVID-19 molecular diagnostic test for pooled sampling. While the method could speed up testing and use less resources, it also can result in false negatives.